Linoleate sodium is an orally active IL8 regulator via the JNK and NF-kappaB pathway. Linoleate sodium can change the composition of fatty acids and the production of metabolites in cells. Linoleate sodium has anti-inflammatory, immune-regulating, and tumor cell growth-affecting activities[1][2][3][4][5][6][7][8][9].